Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Surveillance length and validity of benchmarks for central line-associated bloodstream infection incidence rates in intensive care units.

Fontela PS, Quach C, Buckeridge D, Pai M, Platt RW.

PLoS One. 2012;7(5):e36582. doi: 10.1371/journal.pone.0036582. Epub 2012 May 7.

2.

Central line-associated bloodstream infections in limited-resource countries: a review of the literature.

Rosenthal VD.

Clin Infect Dis. 2009 Dec 15;49(12):1899-907. doi: 10.1086/648439. Review.

PMID:
19911941
3.

Central line-associated bloodstream infection prevention.

Miller SE, Maragakis LL.

Curr Opin Infect Dis. 2012 Aug;25(4):412-22. doi: 10.1097/QCO.0b013e328355e4da. Review.

PMID:
22766647
4.

A systematic review of strategies for reporting of neonatal hospital-acquired bloodstream infections.

Folgori L, Bielicki J, Sharland M.

Arch Dis Child Fetal Neonatal Ed. 2013 Nov;98(6):F518-23. doi: 10.1136/archdischild-2012-303149. Epub 2013 May 4. Review.

PMID:
23645589
5.

Is it possible to achieve a target of zero central line associated bloodstream infections?

Worth LJ, McLaws ML.

Curr Opin Infect Dis. 2012 Dec;25(6):650-7. doi: 10.1097/QCO.0b013e32835a0d1a. Review.

PMID:
23041775
6.

Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis.

Ziegler MJ, Pellegrini DC, Safdar N.

Infection. 2015 Feb;43(1):29-36. doi: 10.1007/s15010-014-0689-y. Epub 2014 Oct 21. Review.

PMID:
25331552
7.

Benchmarking local healthcare-associated infections: available benchmarks and interpretation challenges.

El-Saed A, Balkhy HH, Weber DJ.

J Infect Public Health. 2013 Oct;6(5):323-30. doi: 10.1016/j.jiph.2013.05.001. Epub 2013 Jun 5. Review.

Supplemental Content

Support Center